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The inhibitory glycine receptor (GlyR) is a ligandagated chloride channel protein, whose ligand binding a subunit occurs in several isoforrns in 
the mammalian centrdl nervous ystem. Here we show that coexpression ofthe GlyR-associated protein gephyrin changes the agonist and antagonist 
binding affinities of GlyRs generated by a2 subunit expression in 293 kidney cells, Thus, a receptor-associated protein modifies the functional 
properties of a neurotransmitter receptor, This may contribute to an optimization of the postsynaptic neurotransmitter response. 
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1. INTRODUCTION 
The inhibitory glycine receptor (GlyR) is a chloride 
channel protein that antagonizes neuronal firing in spi- 
nal cord and other regions of the central nervous system 
[1,2]. The pentameric receptor is composed of homolo- 
gous ligand binding Q and structural /J subunits, which 
arrange into an anion selective transmembrane channel 
[3-61. A peripheral membrane protein of 93 kDa has 
been shown to co-purify with the CilyR [3,7,8] and to be 
localized at the cytoplasmic face of glycinergic postsyn- 
aptic membranes [9,10]. This associated protein, re- 
cently named gephyrin [I 1,121 binds with high affinity 
to polymerized tubulin [13]. Gephyrin, therefore, has 
been implicated in the anchoring and/or clustering of 
GlyRs in the postsynaptic membrane [6,13]. 
Immunological and molecular cloning data indicate 
a considerable heterogeneity of GlyR 41 subunits in the 
mammalian brain [WlS]. Presently three a subunit 
variants, c+a3, have been characterized in detail [15- 
181, which all form glycine-gated chloride channels 
upon heterologous expression in Xerropus oocytes [16- 
19] or mammalian cell lines [20]. The pharmacology of 
these homooligomeric GlyRs is very similar to that 
found for in vivo receptors; however, higher agonist 
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concentrations are required for channel gating. More- 
over, in case of neonatal GlyRs, which contain cr, as the 
ligand binding subunit [17], significant differences in 
sensitivity to the glycinergic antagonist strychnine have 
been revealed by biochemical, electrophysiological nd 
heterologous expression experiments [2,14,16,17]. 
These discrepancies may relate to the lack of additional 
subunits [3,5]. Alternatively, other components or mod- 
ifications specifically occurring in neuronal cells may be 
required. In this paper we show that coexpression of 
gephyrin [7-91 changes the ligand binding affinities of 
tz, GlyRs. Thus, interactions of neurotransmitter recep- 
tors with associated proteins may play a crucial role in 
shaping postsynaptic receptor properties. 
2. MATERIALS AND METHODS 
2.1. TmrsJraiott of 293 kidney cells 
The human CilyR a: [16] and the rat GlyR a, [18] and/3 [5] subunit 
cDNAs as well as the rat gephyrin pl cDNA [S]. each subcloned into 
the eukarydtic expression vector pCIS, were used to transfcct he 
human ombyronic kidney cell line 293 (ATCC CRL1573) by calcium 
phosphate precipitation as described [20]. For electrophysiological 
measurements, the cells were grown on fibronectin-coated cover slips 
(Thecmanox) and used for recording 40-50 h after transfcction. 
2.2. Wesrrrrt b/o/ring 
Western blot nnalysis of membrane fractions from the transfected 
cells was performed with the monoclonal antibody GlyR Sa [4] as 
described [20]. 
2.3. Elecrroplr~siologicai recordings 
Voltage-clamp recording of membrane currents from 293 cells 
maintained on covcrslips was done as detailed previously using a 
holding potential of -60 mV [20]. Whole-cell current traces were 
digitally stored on a personal computer and filtered at 100 Hz before 
evaluating agonist-induced currents. 
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3. RESULTS AND DISCUSSION 
To investigate the association of gephyrin with GlyR 
proteins, we co-transfected 293 kidney cells with human 
oc2 subunit and gephyrin cDNAs engineered for high- 
level expression. Both proteins were efficiently synthe- 
sized under these conditions as revealed by (i) Western 
blotting of membrane fractions with mAbSa, a mono- 
clonal antibody selective for gephyrin [4], and (ii) elec- 
trophysiological detection of glycine responses in the 
transfected cells (data not shown). Previous studies have 
demonstrated that the human GlyR CL? subunit forms 
strychnine-sensitive chloride channels upon heterolo- 
gous expression in Xenopus oocytes [16]. Accordingly, 
large glycine-gated currents were revealed here in co- 
transfected cells by voltage-clamp recording (Fig. 1). 
Interestingly, however, the pharmacology of these re- 
sponses differed from that of the channels folmed from 
the oc2 cDNA alone. Whereas responses to 100 PM 
glycine in a, transfected cells were readily blocked by 
1 PM of the high-affinity antagonist strychnine, glycine 
currents of cells co-transfected with a? and gephyrin 
cDNAs displayed a significantly lower sensitivity to this 
alkaloid (Fig. 1). Dose-response curves obtained at 100 
AM agonist revealed half-maximal inhibition (IC,,) val- 
ues for strychnine of 140 nM for a2 and 1.8 yM for 
co-transfected cells, respectively (Table I). 
Further analysis tif the glycine responses of singly- 
and co-transfected cells showed that co-expression of 
gephyrin also produced an increase in agonist affinity. 
As shown in Fig. 2, the concentration of glycine re- 
quired for eliciting a half-maximal response decreased 
from about 80 to 20 (uM upon co-transfection of the 
cells with gephyrin cDNA. Different control experi- 
ments showed that the observed changes in agonist 
A 
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Fig. 1, Strychnine inhibition or glycine responses recorded from 293 
cdls transfected with either (A) oz. or (B) both a: and pephyrin, 
cDNAs. Responses to 100 PM glycine were recorded 2 days after 
transfection in the absence or presence of 1 ,uM strychnine. Bars 
indicate the duration of agonist and antagonist application; note dif- 
ferent current scales in (A) and (B). 
Fig. 2. Glycine dose-response curves obtained from 293 cells trans- 
feckd with either (0) az, or (0) both q and gephyrin, cDNAs. Re- 
sponses to increasing concentrations ofagonist represent mean values 
from 2-3 independent transfection experiments. Ban indicate SD. 
binding were not due to unspecific effects of co-transfec- 
tion. First, transfection of 293 cells with Q and j3 sub- 
unit cDNAs, or with cc, and gephyrin cDNAs, did not 
significantly alter the glycine response and strychnine 
sensitivities of the resulting c+ and a3 receptors (Table 
I). Second, co-transfection of an expression plasmid 
harbouring a cDNA encoding synaptophysin [21] also 
did not alter the response of ck_ and 01~ GlyRs (not 
shown). Thus, the gephyrin protein expressed in this 
study appears to affect ul, but not a3, receptors; this 
may indicate that different isoforms of gephyrin gener- 
ated by alternative splicing [8] are differentially associ- 
ated with the various GlyR isoforms. In conclusion, the 
pharmacological properties of the GlyR were signifi- 
cantly modified in the presence of gephyrin. 
The data presented here indicate that gephyrin alters 
the pharmacological properties of a, GlyRs. Presuma- 
bly, gephyrin acts by binding to and clustering of recep 
tors, which are otherwise diffusely distributed in the 
plasma membrane [2,7,8,13]. The hypothesis of en- 
hanced ligand affinity resulting from receptor clustering 
is supported by recent data from our laboratory, which 
demonstrate increases in the agonist binding affinity of 
aI GlyRs generated by over-expression in Xenopus 
Table I 
Coexpression of gephyrin alters the pharmacology of al, but not a3, 
GlyRs 
cDNAs trdnsfected IC, strychnine E&, glycinc 
(W WM) 
az MO+ 43 7s + 14 
IL* + gephyrin 18OOf374 202 3 
a? +B 1oOf 21 8Oi 8 
a1 16Of 8 ss 2 10 
a, + gephyrin 220 f 33 6Sk 7 
Apparent ICa values ior st@rlline were determined ai a g!ycir% 
concentration of IOOyM as described [18.19]. ECW vnlues for glycinc 
were estimated from responses obtained with at least 6-7 different 
concentrations of agonist (S-SO0 PM). 
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oocytes (0. Taleb and H. Betz, in preparation), In other 
words, the dense packing of GlyRs, and possibly other 
receptors, in the postsynaptic membrane may have 
functional consequences on the neurotransmitter re- 
sponse. We speculate that inter-receptor cooperatively 
resulting from lateral interaction of individual receptors 
[22] may substitute to some extent for intra-receptor 
cooperativity [19] of agonist binding, thus allowing 
channel opening at a lower fractional occupancy by the 
agonist. As a consequence, ‘packing’ of receptors at 
postsynaptic membrane domains by association with 
cytoskeleton binding proteins may represent a central 
step in the functional maturation of synapses. 
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